Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death
Abstract The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy. Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is characterized by the emission of damage-associated molecular patterns (DAMPs) from dying cells. This emission can trigger eff...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-86354-4 |
id |
doaj-41e549963f9b4302b7339409a3df2132 |
---|---|
record_format |
Article |
spelling |
doaj-41e549963f9b4302b7339409a3df21322021-04-04T11:33:10ZengNature Publishing GroupScientific Reports2045-23222021-03-0111111310.1038/s41598-021-86354-4Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell deathVictoria D. Turubanova0Tatiana A. Mishchenko1Irina V. Balalaeva2Iuliia Efimova3Nina N. Peskova4Larisa G. Klapshina5Svetlana A. Lermontova6Claus Bachert7Olga Krysko8Maria V. Vedunova9Dmitri V. Krysko10Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny NovgorodInstitute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny NovgorodInstitute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny NovgorodCell Death Investigation and Therapy Laboratory, Department of Human Structure and Repair, Ghent UniversityInstitute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny NovgorodG.A. Razuvaev Institute of Organometallic Chemistry of the Russian Academy of SciencesG.A. Razuvaev Institute of Organometallic Chemistry of the Russian Academy of SciencesUpper Airways Research Laboratory, Department of Head and Skin, Ghent UniversityUpper Airways Research Laboratory, Department of Head and Skin, Ghent UniversityInstitute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny NovgorodInstitute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny NovgorodAbstract The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy. Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is characterized by the emission of damage-associated molecular patterns (DAMPs) from dying cells. This emission can trigger effective anti-tumor immunity. Only a few photosensitizers are known to induce ICD and, therefore, there is a need for development of new photosensitizers that can induce ICD. The purpose of this work was to analyze whether photosensitizers developed in-house from porphyrazines (pz I and pz III) can induce ICD in vitro and in vivo when used in PDT. We indetified the optimal concentrations of the photosensitizers and found that, at a light dose of 20 J/cm2 (λex 615–635 nm), both pz I and pz III efficiently induced cell death in cancer cells. We demonstrate that pz I localized predominantly in the Golgi apparatus and lysosomes while pz III in the endoplasmic reticulum and lysosomes. The cell death induced by pz I-PDT was inhibited by zVAD-fmk (apoptosis inhibitor) but not by ferrostatin-1 and DFO (ferroptosis inhibitors) or by necrostatin-1 s (necroptosis inhibitor). By contrast, the cell death induced by pz III-PDT was inhibited by z-VAD-fmk and by the necroptosis inhibitor, necrostatin-1 s. Cancer cells induced by pz I-PDT or pz III-PDT released HMGB1 and ATP and were engulfed by bone marrow-derived dendritic cells, which then matured and became activated in vitro. We demonstrate that cancer cells, after induction of cell death by pz I-PDT or pz III-PDT, are protective when used in the mouse model of prophylactic tumor vaccination. By vaccinating immunodeficient mice, we prove the role of the adaptive immune system in protecting against tumours. All together, we have shown that two novel porphyrazines developed in-house are potent ICD inducers that could be effectively applied in PDT of cancer.https://doi.org/10.1038/s41598-021-86354-4 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Victoria D. Turubanova Tatiana A. Mishchenko Irina V. Balalaeva Iuliia Efimova Nina N. Peskova Larisa G. Klapshina Svetlana A. Lermontova Claus Bachert Olga Krysko Maria V. Vedunova Dmitri V. Krysko |
spellingShingle |
Victoria D. Turubanova Tatiana A. Mishchenko Irina V. Balalaeva Iuliia Efimova Nina N. Peskova Larisa G. Klapshina Svetlana A. Lermontova Claus Bachert Olga Krysko Maria V. Vedunova Dmitri V. Krysko Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death Scientific Reports |
author_facet |
Victoria D. Turubanova Tatiana A. Mishchenko Irina V. Balalaeva Iuliia Efimova Nina N. Peskova Larisa G. Klapshina Svetlana A. Lermontova Claus Bachert Olga Krysko Maria V. Vedunova Dmitri V. Krysko |
author_sort |
Victoria D. Turubanova |
title |
Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death |
title_short |
Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death |
title_full |
Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death |
title_fullStr |
Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death |
title_full_unstemmed |
Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death |
title_sort |
novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death |
publisher |
Nature Publishing Group |
series |
Scientific Reports |
issn |
2045-2322 |
publishDate |
2021-03-01 |
description |
Abstract The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy. Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is characterized by the emission of damage-associated molecular patterns (DAMPs) from dying cells. This emission can trigger effective anti-tumor immunity. Only a few photosensitizers are known to induce ICD and, therefore, there is a need for development of new photosensitizers that can induce ICD. The purpose of this work was to analyze whether photosensitizers developed in-house from porphyrazines (pz I and pz III) can induce ICD in vitro and in vivo when used in PDT. We indetified the optimal concentrations of the photosensitizers and found that, at a light dose of 20 J/cm2 (λex 615–635 nm), both pz I and pz III efficiently induced cell death in cancer cells. We demonstrate that pz I localized predominantly in the Golgi apparatus and lysosomes while pz III in the endoplasmic reticulum and lysosomes. The cell death induced by pz I-PDT was inhibited by zVAD-fmk (apoptosis inhibitor) but not by ferrostatin-1 and DFO (ferroptosis inhibitors) or by necrostatin-1 s (necroptosis inhibitor). By contrast, the cell death induced by pz III-PDT was inhibited by z-VAD-fmk and by the necroptosis inhibitor, necrostatin-1 s. Cancer cells induced by pz I-PDT or pz III-PDT released HMGB1 and ATP and were engulfed by bone marrow-derived dendritic cells, which then matured and became activated in vitro. We demonstrate that cancer cells, after induction of cell death by pz I-PDT or pz III-PDT, are protective when used in the mouse model of prophylactic tumor vaccination. By vaccinating immunodeficient mice, we prove the role of the adaptive immune system in protecting against tumours. All together, we have shown that two novel porphyrazines developed in-house are potent ICD inducers that could be effectively applied in PDT of cancer. |
url |
https://doi.org/10.1038/s41598-021-86354-4 |
work_keys_str_mv |
AT victoriadturubanova novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT tatianaamishchenko novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT irinavbalalaeva novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT iuliiaefimova novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT ninanpeskova novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT larisagklapshina novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT svetlanaalermontova novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT clausbachert novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT olgakrysko novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT mariavvedunova novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath AT dmitrivkrysko novelporphyrazinebasedphotodynamicanticancertherapyinducesimmunogeniccelldeath |
_version_ |
1721542589056811008 |